Table 3. Kinases inhibitory activities (VEGFR2, FAK and HER-3) of representative compounds (C9, C10, C13, C15, C17 and C20).

Compounds	IC50(μM)	IC50(μM)	IC50(μM)
	VEGFR-2	FAK	HER-3
C9	11.5 ± 1.07	36.1 ± 3.21	6.32 ± 0.58
C10	6.91 ± 0.64	64.0 ± 5.95	10.7 ± 0.96
C13	25.8 ± 2.41	36.5 ± 3.42	2.46 ± 0.23
C15	8.75 ± 0.77	40.3 ± 3.88	17.9 ± 1.48
C17	5.16 ± 0.50	30.1 ± 2.76	8.45 ± 0.78
C20	18.4 ± 1.74	56.2 ± 5.48	5.20 ± 0.46